LT2670432T - Imunogeninės bordetalla bronchiseptica kompozicijos - Google Patents

Imunogeninės bordetalla bronchiseptica kompozicijos

Info

Publication number: LT2670432T
Authority: LT; Lithuania
Prior art keywords: immunogenic; compositions; bordetella bronchiseptica; bronchiseptica; bordetella
Prior art date: 2011-02-04

Application number

LTEP12705438.5T

Other languages

English (en)

Inventor

Omar ABDELMAGID

Joseph BRICKER

Shelly Shields

Jeffrey Galvin

Original Assignee

Zoetis Services Llc

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2011-02-04

Filing date

2012-02-03

Publication date

2021-05-25

2012-02-03 Application filed by Zoetis Services Llc filed Critical Zoetis Services Llc

2021-05-25 Publication of LT2670432T publication Critical patent/LT2670432T/lt

Links

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/02—Bacterial antigens
- A61K39/099—Bordetella
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
- A61K39/295—Polyvalent viral antigens; Mixtures of viral and bacterial antigens
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/02—Bacterial antigens
- A61K39/0241—Mollicutes, e.g. Mycoplasma, Erysipelothrix
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/02—Bacterial antigens
- A61K39/098—Brucella
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/16—Antivirals for RNA viruses for influenza or rhinoviruses
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
- C07K14/235—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Bordetella (G)
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/02—Bacterial antigens
- A61K2039/10—Brucella; Bordetella, e.g. Bordetella pertussis; Not used, see subgroups
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/525—Virus
- A61K2039/5252—Virus inactivated (killed)
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/525—Virus
- A61K2039/5254—Virus avirulent or attenuated
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
- A61K2039/552—Veterinary vaccine
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55505—Inorganic adjuvants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55511—Organic adjuvants
- A61K2039/55566—Emulsions, e.g. Freund's adjuvant, MF59
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55511—Organic adjuvants
- A61K2039/55577—Saponins; Quil A; QS21; ISCOMS
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/70—Multivalent vaccine
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
- C12N2710/00011—Details
- C12N2710/10011—Adenoviridae
- C12N2710/10034—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
- C12N2760/00011—Details
- C12N2760/16011—Orthomyxoviridae
- C12N2760/16111—Influenzavirus A, i.e. influenza A virus
- C12N2760/16134—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
- C12N2760/00011—Details
- C12N2760/18011—Paramyxoviridae
- C12N2760/18611—Respirovirus, e.g. Bovine, human parainfluenza 1,3
- C12N2760/18634—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
- C12N2770/00011—Details
- C12N2770/20011—Coronaviridae
- C12N2770/20034—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
General Health & Medical Sciences (AREA)
Animal Behavior & Ethology (AREA)
Pharmacology & Pharmacy (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Organic Chemistry (AREA)
Virology (AREA)
Immunology (AREA)
Microbiology (AREA)
Mycology (AREA)
Epidemiology (AREA)
Chemical Kinetics & Catalysis (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Chemical & Material Sciences (AREA)
Molecular Biology (AREA)
Oncology (AREA)
Communicable Diseases (AREA)
Gastroenterology & Hepatology (AREA)
Biochemistry (AREA)
Biophysics (AREA)
Genetics & Genomics (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Pulmonology (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

LTEP12705438.5T 2011-02-04 2012-02-03 Imunogeninės bordetalla bronchiseptica kompozicijos LT2670432T (lt)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
US201161439597P	2011-02-04	2011-02-04
PCT/IB2012/050512 WO2012104821A1 (en)	2011-02-04	2012-02-03	Immunogenic bordetella bronchiseptica compositions

Publications (1)

Publication Number	Publication Date
LT2670432T true LT2670432T (lt)	2021-05-25

Family

ID=45755432

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
LTEP12705438.5T LT2670432T (lt)	2011-02-04	2012-02-03	Imunogeninės bordetalla bronchiseptica kompozicijos

Country Status (26)

Country	Link
US (1)	US20130302369A1 (lt)
EP (2)	EP3858381A1 (lt)
JP (1)	JP5833145B2 (lt)
KR (1)	KR101647180B1 (lt)
CN (2)	CN107296955B (lt)
AU (2)	AU2012213035A1 (lt)
BR (1)	BR112013019675B8 (lt)
CA (1)	CA2826060C (lt)
CL (1)	CL2013002219A1 (lt)
CO (1)	CO6791568A2 (lt)
CY (1)	CY1124093T1 (lt)
DK (1)	DK2670432T3 (lt)
ES (1)	ES2869175T3 (lt)
HK (1)	HK1245676A1 (lt)
HR (1)	HRP20210575T1 (lt)
HU (1)	HUE055669T2 (lt)
LT (1)	LT2670432T (lt)
MX (1)	MX347177B (lt)
PL (1)	PL2670432T3 (lt)
PT (1)	PT2670432T (lt)
RS (1)	RS61723B1 (lt)
RU (1)	RU2554480C2 (lt)
SI (1)	SI2670432T1 (lt)
UA (2)	UA110505C2 (lt)
WO (1)	WO2012104821A1 (lt)
ZA (1)	ZA201306615B (lt)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
KR102090740B1 (ko)	2011-10-03	2020-03-18	엠엑스 아쥬바크 에이비	암 치료 및 식품 관련 화합물을 포함하는 의학 분야에서 양친매성 또는 소수성 분자를 위한 나노입자, 제조 방법 및 담체로의 용도
CN104411330B (zh) *	2012-05-31	2017-02-22	佐蒂斯有限责任公司	用犬呼吸道冠状病毒进行疫苗接种以针对支气管炎博德特菌感染进行保护
CN109675025A (zh)	2013-09-19	2019-04-26	硕腾服务有限责任公司	油基佐剂
CA2932878C (en) *	2013-11-26	2020-11-03	Zoetis Services Llc	Compositions for induction of immune response
US10478487B2 (en)	2015-01-16	2019-11-19	Zoetis Services Llc	Foot-and-mouth disease vaccine
EP3909971A1 (en)	2020-09-28	2021-11-17	Institute of Life Sciences (ILS)	Whole cell livestock vaccine for respiratory diseases

Family Cites Families (21)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
FR2571618A1 (fr)	1984-10-12	1986-04-18	Virbac Ctre Rech Biolog	Nouveau vaccin contre la tracheobronchite infectieuse canine et son procede de preparation
US5019388A (en) *	1986-10-14	1991-05-28	Norden Laboratories Inc.	Bordetella bronchiseptica vaccine
US4888169A (en) *	1986-10-14	1989-12-19	Norden Laboratories, Inc.	Bordetella Bronchiseptica vaccine
US5703055A (en)	1989-03-21	1997-12-30	Wisconsin Alumni Research Foundation	Generation of antibodies through lipid mediated DNA delivery
AU724743B2 (en) *	1996-05-31	2000-09-28	Genetics Institute, Llc	IL-12 as an adjuvant for Bordetella Pertussis vaccines
BR9710460A (pt) *	1996-07-02	1999-08-17	Connaught Lab	Composi-Æo imunolÄgica multi-valente e seu uso em vacinas
WO2001090143A2 (en) *	2000-05-25	2001-11-29	Institut Pasteur	Polypeptides containing polymorphisms of the repeated regions of pertactin in bordetella pertussis, bordetella parapertussis and bordetella bronchiseptica. their use in diagnostics, and in immunogenic compositions
GB0217434D0 (en) *	2002-07-27	2002-09-04	Royal Vetinary College	Biological material
BRPI0407032A (pt)	2003-01-29	2006-01-17	Pfizer Prod Inc	Vacinas caninas contra bordetella bronchiseptica
US20050089533A1 (en) *	2003-01-29	2005-04-28	Joseph Frantz	Canine vaccines against Bordetella bronchiseptica
GB0315323D0 (en)	2003-07-01	2003-08-06	Royal Veterinary College	Vaccine composition
WO2005032584A2 (en) *	2003-10-02	2005-04-14	Glaxosmithkline Biologicals S.A.	Pertussis antigens and use thereof in vaccination
US7572620B2 (en)	2005-01-11	2009-08-11	Wisconsin Alumni Research Foundation	H3 equine influenza A virus
CA2604488A1 (en) *	2005-04-07	2006-10-12	Pharmacia & Upjohn Company Llc	Formulations and process for production of bordetella bronchiseptica p68 antigen and vaccines
US7959929B2 (en)	2005-04-21	2011-06-14	University Of Florida Research Foundation, Inc.	Materials and methods for respiratory disease control in canines
US7384642B2 (en)	2005-08-25	2008-06-10	Merial Limited	Canine influenza vaccines
WO2007042884A1 (en) *	2005-10-07	2007-04-19	Pfizer Products Inc.	Vaccines and methods to treat canine influenza
US7468187B2 (en) *	2005-10-18	2008-12-23	Iowa State University Research Foundation, Inc.	Canine influenza virus and related compositions and methods of use
WO2007047728A2 (en) *	2005-10-20	2007-04-26	Wyeth	Compositions and methods for the treatment of canine influenza virus disease
US7682619B2 (en) *	2006-04-06	2010-03-23	Cornell Research Foundation, Inc.	Canine influenza virus
US20090304735A1 (en) *	2006-05-19	2009-12-10	Gabrielle Therese Belz	Immunogenic Compositions

2012
- 2012-02-03 PL PL12705438T patent/PL2670432T3/pl unknown
- 2012-02-03 US US13/983,127 patent/US20130302369A1/en active Pending
- 2012-02-03 SI SI201231911T patent/SI2670432T1/sl unknown
- 2012-02-03 CA CA2826060A patent/CA2826060C/en active Active
- 2012-02-03 WO PCT/IB2012/050512 patent/WO2012104821A1/en active Application Filing
- 2012-02-03 KR KR1020137022854A patent/KR101647180B1/ko active IP Right Grant
- 2012-02-03 CN CN201710294793.6A patent/CN107296955B/zh active Active
- 2012-02-03 RS RS20210474A patent/RS61723B1/sr unknown
- 2012-02-03 LT LTEP12705438.5T patent/LT2670432T/lt unknown
- 2012-02-03 PT PT127054385T patent/PT2670432T/pt unknown
- 2012-02-03 ES ES12705438T patent/ES2869175T3/es active Active
- 2012-02-03 CN CN201280015807.1A patent/CN103561763A/zh active Pending
- 2012-02-03 BR BR112013019675A patent/BR112013019675B8/pt active IP Right Grant
- 2012-02-03 EP EP21162470.5A patent/EP3858381A1/en active Pending
- 2012-02-03 EP EP12705438.5A patent/EP2670432B1/en active Active
- 2012-02-03 HU HUE12705438A patent/HUE055669T2/hu unknown
- 2012-02-03 JP JP2013552317A patent/JP5833145B2/ja active Active
- 2012-02-03 RU RU2013136151/10A patent/RU2554480C2/ru active
- 2012-02-03 DK DK12705438.5T patent/DK2670432T3/da active
- 2012-02-03 MX MX2013009012A patent/MX347177B/es active IP Right Grant
- 2012-02-03 AU AU2012213035A patent/AU2012213035A1/en not_active Abandoned
- 2012-03-02 UA UAA201309553A patent/UA110505C2/ru unknown
- 2012-03-02 UA UAA201309552A patent/UA110504C2/ru unknown
2013
- 2013-08-02 CO CO13184705A patent/CO6791568A2/es not_active Application Discontinuation
- 2013-08-02 CL CL2013002219A patent/CL2013002219A1/es unknown
- 2013-09-03 ZA ZA2013/06615A patent/ZA201306615B/en unknown
2014
- 2014-04-10 HK HK18105491.3A patent/HK1245676A1/zh unknown
2017
- 2017-05-15 AU AU2017203244A patent/AU2017203244B2/en active Active
2021
- 2021-04-12 HR HRP20210575TT patent/HRP20210575T1/hr unknown
- 2021-05-06 CY CY20211100386T patent/CY1124093T1/el unknown

Also Published As

Publication number	Publication date
PL2670432T3 (pl)	2021-10-11
CA2826060A1 (en)	2012-08-09
ES2869175T3 (es)	2021-10-25
PT2670432T (pt)	2021-05-04
EP2670432A1 (en)	2013-12-11
CY1124093T1 (el)	2022-05-27
RU2013136151A (ru)	2015-03-10
MX2013009012A (es)	2013-12-06
NZ613759A (en)	2015-09-25
JP2014504635A (ja)	2014-02-24
HUE055669T2 (hu)	2021-12-28
RS61723B1 (sr)	2021-05-31
AU2017203244A1 (en)	2017-06-08
UA110504C2 (ru)	2016-01-12
MX347177B (es)	2017-04-17
HK1245676A1 (zh)	2018-08-31
WO2012104821A1 (en)	2012-08-09
CL2013002219A1 (es)	2014-01-31
DK2670432T3 (da)	2021-04-19
AU2017203244B2 (en)	2019-05-09
EP2670432B1 (en)	2021-03-17
ZA201306615B (en)	2015-04-29
BR112013019675B1 (pt)	2021-06-22
KR101647180B1 (ko)	2016-08-09
US20130302369A1 (en)	2013-11-14
CN103561763A (zh)	2014-02-05
JP5833145B2 (ja)	2015-12-16
RU2554480C2 (ru)	2015-06-27
CN107296955A (zh)	2017-10-27
AU2012213035A1 (en)	2013-08-15
BR112013019675B8 (pt)	2022-11-22
CO6791568A2 (es)	2013-11-14
SI2670432T1 (sl)	2021-08-31
KR20130118975A (ko)	2013-10-30
CA2826060C (en)	2019-06-18
CN107296955B (zh)	2021-11-23
HRP20210575T1 (hr)	2021-05-28
UA110505C2 (ru)	2016-01-12
BR112013019675A2 (pt)	2017-01-31
EP3858381A1 (en)	2021-08-04

Publication	Publication Date	Title
HK1231412A1 (zh)	2017-12-22	免疫原性組合物
EP2809349A4 (en)	2015-08-26	IMMUNOGENIC COMPOSITION
PT2714911T (pt)	2017-02-06	Composição imunogénica
IL238079A0 (en)	2015-05-31	Immunogenic preparation
HUE043091T2 (hu)	2019-08-28	Immunogén készítmény
IL237431A0 (en)	2015-04-30	Immunogenic preparations
GB201223342D0 (en)	2013-02-06	Immunogenic composition
HK1245676A1 (zh)	2018-08-31	免疫原性支氣管炎博德特氏菌組合物
GB201218660D0 (en)	2012-11-28	Immunogenic composition
GB201100683D0 (en)	2011-03-02	Compositions & methods
GB201204968D0 (en)	2012-05-02	Immunogenic composition
GB201204851D0 (en)	2012-05-02	Immunogenic composition